Aldeyra Therapeutics Inc (ALDX)
5.345
+0.12
(+2.20%)
USD |
NASDAQ |
Oct 04, 16:00
5.50
+0.16
(+2.90%)
After-Hours: 20:00
Aldeyra Therapeutics Research and Development Expense (TTM): 32.41M for June 30, 2024
Research and Development Expense (TTM) Chart
Historical Research and Development Expense (TTM) Data
| Date | Value |
|---|---|
| June 30, 2024 | 32.41M |
| March 31, 2024 | 24.41M |
| December 31, 2023 | 29.46M |
| September 30, 2023 | 34.12M |
| June 30, 2023 | 38.70M |
| March 31, 2023 | 46.31M |
| December 31, 2022 | 47.31M |
| September 30, 2022 | 51.19M |
| June 30, 2022 | 52.54M |
| March 31, 2022 | 49.44M |
| December 31, 2021 | 44.94M |
| September 30, 2021 | 39.12M |
| June 30, 2021 | 32.36M |
| March 31, 2021 | 25.77M |
| December 31, 2020 | 24.68M |
| September 30, 2020 | 27.27M |
| June 30, 2020 | 37.36M |
| March 31, 2020 | 43.14M |
| December 31, 2019 | 44.35M |
| September 30, 2019 | 43.29M |
| June 30, 2019 | 34.94M |
| March 31, 2019 | 31.07M |
| Date | Value |
|---|---|
| December 31, 2018 | 29.82M |
| September 30, 2018 | 26.82M |
| June 30, 2018 | 22.48M |
| March 31, 2018 | 19.53M |
| December 31, 2017 | 16.30M |
| September 30, 2017 | 14.20M |
| June 30, 2017 | 14.04M |
| March 31, 2017 | 13.03M |
| December 31, 2016 | 13.17M |
| September 30, 2016 | 12.84M |
| June 30, 2016 | 11.53M |
| March 31, 2016 | 9.949M |
| December 31, 2015 | 7.574M |
| September 30, 2015 | 5.866M |
| June 30, 2015 | 4.985M |
| March 31, 2015 | 4.400M |
| December 31, 2014 | 3.708M |
| September 30, 2014 | 2.704M |
| June 30, 2014 | 2.175M |
| March 31, 2014 | 1.836M |
| December 31, 2013 | 1.542M |
| September 30, 2013 | 1.238M |
R&D Expense Definition
R&D expense is a line item from many companies' income statements.
Research and Development Expense (TTM) Range, Past 5 Years
24.41M
Minimum
Mar 2024
52.54M
Maximum
Jun 2022
38.15M
Average
38.70M
Median
Jun 2023
Research and Development Expense (TTM) Benchmarks
| AbbVie Inc | 7.537B |
| NovaBay Pharmaceuticals Inc | 0.043M |
| Palatin Technologies Inc | 22.40M |
| iBio Inc | 5.185M |
| Theriva Biologics Inc | 14.61M |